Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
TRX INC (TRXI)
|
Add to portfolio |
|
|
|
| Price: |
$0.60
| | Metrics |
| OS: |
18.5
|
M
| |
104
|
% ROE
|
| Market cap: |
$11.1
|
M
| |
19
|
% ROIC
|
|
Net debt:
|
$956
|
k
| |
0.3
|
x Debt/EBITDA
|
|
EV:
|
$12.1
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$3.4
|
M
| |
3.5
|
x EV/EBITDA
|
|
EBIT
|
$908.0
|
k
| |
13.3
|
x EV/EBIT
|
| EPS |
$33.00
| |
0.0
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 |
| Revenues | 49.4 | 56.7 | 59.3 | 96.2 | 92.1 | 116.3 | 118.6 | 113.5 |
| Revenue growth | -13.0% | -4.4% | -38.3% | 4.5% | -20.8% | -1.9% | 4.5% | 52.3% |
| Cost of goods sold | 35.4 | 34.1 | 80.8 | 50.6 | 59.4 | 67.5 | 77.4 | 77.3 |
| Gross profit | 13.9 | 22.6 | -21.5 | 45.7 | 32.7 | 48.8 | 41.3 | 36.2 |
| Gross margin | 28.2% | 39.8% | -36.2% | 47.5% | 35.5% | 42.0% | 34.8% | 31.9% |
| Selling, general and administrative | 9.4 | 12.1 | 11.0 | 17.2 | 16.2 | 20.2 | 19.3 | 19.9 |
| Research and development | | 3.7 | 4.3 | 12.9 | 13.2 | 11.0 | 11.2 | 13.5 |
| EBIT | 1.1 | 2.7 | -43.2 | 4.9 | -7.9 | 7.5 | 0.8 | -7.1 |
| EBIT margin | 2.3% | 4.8% | -72.9% | 5.1% | -8.5% | 6.5% | 0.7% | -6.3% |
| Pre-tax income | 1.8 | 1.7 | -44.0 | 4.5 | -8.1 | 7.5 | -6.7 | -11.2 |
| Income taxes | 0.5 | -0.4 | 0.0 | 0.8 | -0.1 | 0.2 | 0.0 | 0.0 |
| Tax rate | 27.7% | | 0.1% | 17.3% | 0.6% | 2.8% | 0.0% | 0.0% |
| Net income | 1.3 | 2.1 | -44.0 | 3.7 | -8.0 | 7.3 | -6.7 | -11.2 |
| Net margin | 2.7% | 3.7% | -74.1% | 3.8% | -8.7% | 6.3% | -5.6% | -9.9% |
| |
| Diluted EPS | $0.07 | $0.11 | ($2.39) | $0.20 | ($0.44) | $0.41 | ($0.48) | ($0.91) |
| Shares outstanding (diluted) | 18.7 | 18.5 | 18.4 | 18.4 | 18.3 | 17.7 | 13.8 | 12.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|